Skip to main content
Erschienen in: Wiener klinische Wochenschrift 7-8/2021

20.11.2020 | short report

A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center

verfasst von: Branimir Gjurašin, MD, assistant professor Marija Santini, MD, PhD, Vladimir Krajinović, MD, PhD, Neven Papić, MD, PhD, Anita Atelj, MD, Viktor Kotarski, MD, Juraj Krznarić, MD, Martina Vargović, MD, assistant professor Marko Kutleša, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2021

Einloggen, um Zugang zu erhalten

Summary

Background

Since the beginning of the Corona virus disease 2019 (COVID-19) pandemic the new Severe acute respiratory syndrome coronoavirus 2 (SARS-CoV‑2) virus has been repeatedly compared to the influenza virus; however, the comparison of invasively mechanically ventilated patients with acute respiratory distress syndrome (ARDS) caused by these viruses is very scarce. The purpose of this study was to compare clinical course and laboratory parameters between the most severely ill flu and COVID 19 patients treated with invasive mechanical ventilation (IMV).

Methods

The study was conducted at the intensive care unit (ICU) of the tertiary care hospital in Zagreb, Croatia in the period between November 2018 and July 2020. Investigation included 72 adult patients requiring IMV due to influenza or SARS-CoV‑2 virus infection and 42 patients had influenza and 30 had SARS-CoV‑2 virus infection and the comparison between two etiological groups was conducted.

Results

Invasively mechanically ventilated patients with COVID 19 and influenza differ in certain aspects. COVID 19 patients are older, male, have lower C-reactive protein (CRP) levels and have less need for extracorporeal membrane oxygenation (ECMO) support. In other measured variables, including mortality, the difference between influenza or SARS-CoV‑2 etiology was not significant.

Conclusion

High mortality of IMV patients with influenza and COVID 19 with 55% and 63%, respectively, challenges and urges medical and especially ICU community to expand our quest for further treatments, especially since ECMO use that is scarcely required in COVID 19 patients probably has limited impact in reducing mortality in COVID 19 patients.
Literatur
3.
Zurück zum Zitat Dominguez-Cherit G, De la Torre A, Rishu A, et al. Influenza A (H1N1pdm09)-related critical illness and mortality in Mexico and Canada, 2014. Crit Care Med. 2016;44:1861–70.CrossRef Dominguez-Cherit G, De la Torre A, Rishu A, et al. Influenza A (H1N1pdm09)-related critical illness and mortality in Mexico and Canada, 2014. Crit Care Med. 2016;44:1861–70.CrossRef
4.
Zurück zum Zitat Teke T, Coskun R, Sungur M, et al. 2009 H1N1 influenza and experience in three critical care units. Int J Med Sci. 2011;8:270–7.CrossRef Teke T, Coskun R, Sungur M, et al. 2009 H1N1 influenza and experience in three critical care units. Int J Med Sci. 2011;8:270–7.CrossRef
5.
Zurück zum Zitat Tanna K, Vegad MM, Soni ST, et al. Patients with swine flu on mechanical ventilator and its outcome at Civil Hospital, Ahmedabad. Int J Med Sci Public Health. 2015;4:1383–7.CrossRef Tanna K, Vegad MM, Soni ST, et al. Patients with swine flu on mechanical ventilator and its outcome at Civil Hospital, Ahmedabad. Int J Med Sci Public Health. 2015;4:1383–7.CrossRef
7.
Zurück zum Zitat Pelaia C, Tinello C, Vatrella A, et al. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis. 2020;14:1753466620933508.CrossRef Pelaia C, Tinello C, Vatrella A, et al. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications. Ther Adv Respir Dis. 2020;14:1753466620933508.CrossRef
10.
Zurück zum Zitat Ishiguro T, Kagiyama N, Uozumi R, et al. Risk factors for the severity and mortality of pneumococcal pneumonia: importance of premorbid patients’ performance status. J Infect Chemother. 2016;22:685–91.CrossRef Ishiguro T, Kagiyama N, Uozumi R, et al. Risk factors for the severity and mortality of pneumococcal pneumonia: importance of premorbid patients’ performance status. J Infect Chemother. 2016;22:685–91.CrossRef
11.
Zurück zum Zitat Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.CrossRef Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.CrossRef
Metadaten
Titel
A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center
verfasst von
Branimir Gjurašin, MD
assistant professor Marija Santini, MD, PhD
Vladimir Krajinović, MD, PhD
Neven Papić, MD, PhD
Anita Atelj, MD
Viktor Kotarski, MD
Juraj Krznarić, MD
Martina Vargović, MD
assistant professor Marko Kutleša, MD, PhD
Publikationsdatum
20.11.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 7-8/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-020-01759-x

Weitere Artikel der Ausgabe 7-8/2021

Wiener klinische Wochenschrift 7-8/2021 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month